Pharmaceutical Executive

Pharmaceutical Executive Podcast

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

Subscribe Listen in podnod RSS feed Show website

412 episodes
Updated Friday

Episodes412

Newest first

Mar 19, 2020 · 15 min
Episode 52: Cannabinoids
Yuval Cohen, CEO of Corbus Pharmaceuticals, talks about cannabinoids, the differences between natural and synthetic products, and how biotechs and pharma are using them to treat disease today.
Mar 5, 2020 · 14 min
Episode 51: Combating Coronavirus
Dr. Eric von Hofe, Chief Scientific Officer at NuGenerex Immuno-Oncology talks about the recent outbreak of Wuhan coronavirus around the world and how biotechs and pharma are jumping in to help find a solution.
Feb 20, 2020 · 19 min
Episode 50: Pharma Pricing Climate in Washington
Mike Strazzella, head of federal government relations for Buchanan Ingersoll & Rooney, talks about pricing issues in the pharmaceutical industry, the challenges he encounters, and what he believes needs to change in the industry going forward.
Feb 6, 2020 · 23 min
Episode 49: Navigate Emerging Markets with Data Science
Pharm Exec speaks with Nigel Breakwell and Ben Randal, co-founders of Dot I/O Health. Nigel and Ben talk about how they’re using data science in the health and life sciences industries to help clients navigate emerging markets.
Jan 23, 2020 · 21 min
Episode 48: 2020 Industry Outlook
Pharm Exec editors discuss the themes chosen for the January issue focusing on industry trends for the coming year.
Jan 9, 2020 · 9 min
Episode 47: Identifying Adherence Issues
Heather Monte, Director of Operations for DirectRx, talks about the specialty pharma’s new Patient Scorecard, which aims to identify and improve adherence by reporting patients’ prescription patterns to doctors.
Dec 19, 2019 · 14 min
Episode 46: Persistence and Planning Pays Off
Julia Owens, co-founder and CEO of Millendo Therapeutics talks about how to keep a company on the path to success, even when there are bumps in the road. She discusses the value of focusing on strengths and how that is currently working for Millendo in the endocrine space.
Dec 5, 2019 · 27 min
Episode 45: Getting Drug Approval Through FDA LPAD
William Lewis, chairman and CEO of Insmed talks about the approval of the company’s drug Arikayce through the FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs, some ideas that he spoke about on the recent NORD panel about innovative and ethical partnerships, and Insmed’s pipeline and progress.
Nov 21, 2019 · 19 min
Episode 44: Annual Pipeline Report
Pharm Exec editors discuss the articles they focused on for the November Annual Pipeline Report.
Nov 7, 2019 · 23 min
Episode 43: Pharma Reputation
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
Oct 17, 2019 · 14 min
Episode 42: Establishing a New Drug Therapy
Pharm Exec editors interview Mark Glickman, Chief Commercial Officer of Esperion Therapeutics. Glickman discusses the overall cholesterol-lowering space and how it’s planning to add a new therapeutic option for patients, what it means to establish a new therapy in a statin-dominated market, market research approaches, and more.
Oct 3, 2019 · 26 min
Episode 41: The Patient Journey
Jeannine Lynch, senior director at BioMarin Pharmaceuticals, oversees patient access services and talks with editors about the patient journey in regard to receiving therapies, how to engage with patients more effectively, and where she sees the pharma industry in terms of patient engagement and patient centricity.
Sep 19, 2019 · 31 min
Episode 40: Global Pharma Outlook
Janssen’s company group chairman of Europe, Middle East, and Africa operations, Kris Sterkens speaks with Pharm Exec editors. Kris talks about his finance background, global pricing issues, and challenges and opportunities for EMEA biopharma breaking into the US market.
Sep 5, 2019 · 26 min
Episode 39: CEO Builds Business With Compassion
Apellis’ CEO and co-founder, Dr. Cedric Francois talks with editors about his unusual pharma journey, which has included research, clinical work, and the launch of two startups. Today, he’s here to share what he’s learned along the way and how he’s using that experience to improve lives.
Aug 22, 2019 · 13 min
Episode 38: Customer-Centric Innovation
Christine Sakdalan, Head of Franchise Strategy and Customer Solutions at Janssen Pharmaceutical talks with Pharm Exec editors about how patient-centricity fuels innovation, the difference between patient and customer centricity, and educational programs that need to be implemented for patients, providers, and payers.
Aug 8, 2019 · 20 min
Episode 37: Differentiating Yourself in Crowded Therapeutic Areas
Pharm Exec editors sit down with Mark Velleca, CEO of G1 Therapeutics. In this episode, Mark talks about how he differentiates himself in the oncology field, why he considers G1 Therapeutics an "old school company," and about the North Carolina biotech landscape.
Jul 25, 2019 · 30 min
Episode 36: A View from the Editors' Desks
Pharm Exec editors share insights into what they've been working on this summer for the June, July, and August issues; plus a sneak peek into what's coming in September!
Jul 11, 2019 · 27 min
Episode 35: Communicating Your Narrative with Healthcare Marketing
Robert Finkel, the CEO of The FreshBlood Group talks with Pharm Exec editors about the positives and negatives of pharma’s marketing needs, the details and evolution around founding The FreshBlood Group, and how emerging pharma and biotech companies can budget in successful marketing.
Jun 21, 2019 · 23 min
Episode 34: The Future of the Life Sciences Executive
Cameron Turtle, Chief Business Officer of Eidos Therapeutics, Robin Toft, Founder and CEO of The Toft Group Executive Search and Sabrina Johnson, President and CEO, Daré Bioscience join Pharm Exec editors to talk about the future of the life sciences executive.
Jun 11, 2019 · 27 min
Episode 33: Translationally Enabled Pharma
Pharm Exec editors speak with Jigar Raythatha, CEO of Constellation Pharmaceuticals. He talks about his roles, the importance of having a Plan B in biotech, creating a translationally enabled company, and how he leads his team at Constellation.